The natriuretic peptides in cardiovascular medicine

被引：126

作者：

Munagala, VK ^{[1
]}

Burnett, JC ^{[1
]}

Redfield, MM ^{[1
]}

机构：

[1] Mayo Clin, Rochester, MN 55905 USA

来源：

CURRENT PROBLEMS IN CARDIOLOGY | 2004年 / 29卷 / 12期

关键词：

D O I：

10.1016/j.cpcardiol.2004.07.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Within the last five years, assay systems for measurement of plasma levels of brain natriuretic peptide (BNP) have been approved as a diagnostic aid for heart failure (HF). Similarly, nesiritide, a recombinant form of human BNP, has been approved for the treatment of acutely decompensated HE Both BNP as a diagnostic test and a therapeutic modality are rapidly becoming integrated into clinical practice. The purpose of this review is to provide a brief overview of the physiology of the natriuretic peptides relevant to their informed clinical use. The current literature regarding the utility of measuring BNP for the diagnosis and management of HF is reviewed and practical recommendations regarding the interpretation of BNP levels are offered. The clinical literature regarding the use of recombinant BNP for the treatment of HF is reviewed, underscoring current gaps in our knowledge regarding the indications for and benefits of this novel agent.

引用

收藏

页码：707 / 769

页数：63

相关论文

共 158 条

[11] Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT study [J].

Burger, AJ ;

Horton, DP ;

LeJemtel, T ;

Ghali, JK ;

Torre, G ;

Dennish, G ;

Koren, M ;

Dinerman, J ;

Silver, M ;

Cheng, ML ;

Elkayam, U .

AMERICAN HEART JOURNAL, 2002, 144 (06) :1102-1108

[12] Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy [J].

Burger, AJ ;

Elkayam, U ;

Neibaur, MT ;

Haught, H ;

Ghali, J ;

Horton, DP ;

Aronson, D .

AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (01) :35-39

[13] EFFECTS OF SYNTHETIC ATRIAL NATRIURETIC FACTOR ON RENAL-FUNCTION AND RENIN RELEASE [J].

BURNETT, JC ;

GRANGER, JP ;

OPGENORTH, TJ .

AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 247 (05) :F863-F866

[14] ATRIAL-NATRIURETIC-PEPTIDE ELEVATION IN CONGESTIVE-HEART-FAILURE IN THE HUMAN [J].

BURNETT, JC ;

KAO, PC ;

HU, DC ;

HESER, DW ;

HEUBLEIN, D ;

GRANGER, JP ;

OPGENORTH, TJ ;

REEDER, GS .

SCIENCE, 1986, 231 (4742) :1145-1147

[15] Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure [J].

Cataliotti, A ;

Boerrigter, G ;

Costello-Boerrigter, LC ;

Schirger, JA ;

Tsuruda, T ;

Heublein, DM ;

Chen, HH ;

Malatino, LS ;

Burnett, JC .

CIRCULATION, 2004, 109 (13) :1680-1685

[16] Circulating natriuretic peptide concentrations in patients with end-stage renal disease: Role of brain natriuretic peptide as a biomarker for ventricular remodeling [J].

Cataliotti, A ;

Malatino, LS ;

Jougasaki, M ;

Zoccali, C ;

Castellino, P ;

Giacone, G ;

Bellanuova, I ;

Tripepi, R ;

Seminara, G ;

Parlongo, S ;

Stancanelli, B ;

Bonanno, G ;

Fatuzzo, P ;

Rapisarda, F ;

Belluardo, P ;

Signorelli, SS ;

Heublein, DM ;

Lainchbury, JG ;

Leskinen, HK ;

Bailey, KR ;

Redfield, MM ;

Burnett, JC .

MAYO CLINIC PROCEEDINGS, 2001, 76 (11) :1111-1119

[17] Clearance receptors and endopeptidase 24.11: Equal role in natriuretic peptide metabolism in conscious sheep [J].

Charles, CJ ;

Espiner, EA ;

Nicholls, MG ;

Richards, AM ;

Yandle, TG ;

Protter, A ;

Kosoglou, T .

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1996, 271 (02) :R373-R380

[18]

Chen HH, 1998, J CARDIOVASC PHARM, V32, pS22

[19] Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure [J].

Chen, HH ;

Redfield, MM ;

Nordstrom, LJ ;

Horton, DP ;

Burnett, JC .

JOURNAL OF CARDIAC FAILURE, 2004, 10 (02) :115-119

[20] Maximizing the natriuretic peptide system in experimental heart failure - Subcutaneous brain natriuretic peptide and acute vasopeptidase inhibition [J].

Chen, HH ;

Lainchbury, JG ;

Harty, GJ ;

Burnett, JC .

CIRCULATION, 2002, 105 (08) :999-1003

← 1 2 3 4 5 6 7 8 9 10 →